Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Carboplatin is a platinum-based chemotherapy medication used to treat various forms of cancer. It acts by binding to DNA, preventing DNA replication and transcription, ultimately leading to cell death. It is commonly used to treat advanced ovarian cancer, and is also used for lung cancer, head and neck cancers, brain tumors, bladder cancer, breast cancer, and endometrial, cervical, and testicular cancers.
Carboplatin binds to DNA, forming monoadducts and interstrand cross-links. This inhibits DNA replication and transcription, leading to cell death.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Carboplatin.